New application of statin compound as topical medicine for preventing and curing osteoporotic fracture

An osteoporosis and compound technology, applied in the field of medicine, can solve the problems that bones are difficult to ensure the efficacy of surgery, difficult to exert osteogenesis, obstacles to successful bone surgery, etc., to enhance the attachment and convenience, improve the microstructure of bone tissue, The effect of promoting mechanical strength

Pending Publication Date: 2013-06-26
PEKING UNIV THIRD HOSPITAL
View PDF1 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The bioavailability of statins after oral administration is low. After the first-pass effect of the liver, less than 5% enter the blood circulation, and the concentration in the bones is even lower (Schachter M. Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update. Fundam Clin Pharmacol.2005; 19(1): 117-125.), it is difficult to exert effective osteogenesis
[0011] Secondly, many patients with osteoporosis clinically need internal fixation surgery, but loose bones are a huge obstacle to the success of surgery
When internal fixation surgery is required for osteoporosis patients' fractures, spinal degenerative changes, and osteoarthritis, the fragile bones are difficult to guarantee the curative effect of surgery; many patients have not received osteoporosis treatment before surgery, and the existing Osteoporosis Drugs Only Slow Bone Loss, Not Emergency

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • New application of statin compound as topical medicine for preventing and curing osteoporotic fracture
  • New application of statin compound as topical medicine for preventing and curing osteoporotic fracture
  • New application of statin compound as topical medicine for preventing and curing osteoporotic fracture

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0048] Preparation of simvastatin topical injection

[0049] Dissolve 1000 mg of simvastatin in 10 ml of PBS phosphate buffer (purchased from Beijing Zhongshan Jinqiao Biotechnology Co., Ltd.), containing 2% dimethyl sulfoxide (Dimethyl Sulfoxide, DMSO, purchased from Sigma company) and 0.1 % bovine serum albumin (Bovine Serum Albumin, BSA, purchased from Sigma Company), and homogenize the obtained solution to obtain the final product.

Embodiment 2

[0051] Preparation of pravastatin topical injection

[0052] Suspend 1000 mg of pravastatin sodium in 10 ml of fat emulsion (Intralipid), and homogenize the obtained solution.

Embodiment 3

[0054] Fluvastatin topical injection preparation

[0055] Dissolve 1000 mg of fluvastatin sodium in 10 ml of physiological saline containing 3% paloxamer 188 (BSF, Germany), and homogenize the obtained solution.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a new application of statin compound as topical medicine for preventing and curing osteoporotic fracture and enhancing bone plant strength in osteoporotic bone, particularly, discloses a topical statin composite for bone. The topical statin composite can increase bone mass, improve bone density, improve bone tissue microstructure and enhance bone mechanical property, thereby being used for preventing and curing osteoporotic fracture and enhancing the bone plant strength in osteoporotic bone.

Description

technical field [0001] The present invention relates to the field of medical technology, more specifically, relates to the local application of HMG-CoA reductase inhibitors (statins) to prevent and treat osteoporotic fractures, enhance the internal fixation strength of osteoporotic bones, and promote new uses such as fracture healing, and Its topical composition. Background technique [0002] Osteoporosis is a systemic disease characterized by low bone mass and microarchitectural disruption of bone tissue, leading to increased bone fragility and susceptibility to fractures. [0003] With the extension of human life span and the increase of postmenopausal women, osteoporosis and its associated fractures have become a serious public health problem worldwide. Taking the most serious hip fracture as an example, the global incidence in 1990 was 1.66 million, and it is expected to reach 6.26 million in 2050, of which Asia accounts for about 51%. [0004] Although osteoporosis is...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K45/00A61K31/22A61K31/366A61K31/40A61K31/405A61K31/4418A61K31/505A61P19/10
Inventor 宋纯理杨宁徐迎胜党耕町
Owner PEKING UNIV THIRD HOSPITAL
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products